May 20, 2020
Mitsubishi Tanabe Pharma America Announces Launch Of The JourneyMate Program, Offering Live Nurse Educational Phone Support For ALS Patients And Caregivers
May 05, 2020
Mitsubishi Tanabe Pharma America Marks Third Anniversary Of FDA Approval And Reports More Than 5,000 Patients With ALS Treated With RADICAVA® (edaravone)
Apr 21, 2020
Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets
Mar 19, 2020
Global Genetically and Non-Genetically Modified Lecithin Market (2020 to 2026) - Latest Market News and Developments - ResearchAndMarkets.com
Mar 17, 2020
Quillivant XR®, QuilliChew ER® and Dyanavel® XR are 100% Made in the U.S.A. and Remain Consistently Supplied During COVID-19 Pandemic
Jan 24, 2020
Ontario continues to improve access to treatment for children and adolescents living with ADHD who are prescribed INTUNIV XR®*
Jan 17, 2020
Parkinson's Drug Market and Clinical Trial Insights Report, 2020-2025 - Availability, Dosage & Price Analysis on Levodopa/Carbidopa Therapeutics, Dopamine Agonist, MAO B Inhibitors, and More
Dec 17, 2019
BioArctic Announces Research Collaboration with Eisai Regarding BAN2401
Dec 13, 2019
Opting for Optimus - Cognizin® Citicoline Featured in New Drinkable Nootropic Supplement
Nov 25, 2019
Mitsubishi Tanabe Pharma America Announces Initiation of Phase 3 Study Evaluating Investigational Oral Formulation of Edaravone for ALS
Sep 24, 2019
Outlook on China's Polyene Phosphatidylcholine Market, 2019 to 2023 - Sales Value & Volume, Prices, Prospects, Development Trends, Major Manufacturers & Competition
Sep 20, 2019
Mitsubishi Tanabe Pharma America To Present On ALS Clinical Programs At 2019 Muscle Study Group Annual Scientific Meeting
Sep 04, 2019
Tris Pharma Strengthens Its Branded Commercial Leadership Team
Aug 08, 2019
More Than 4,000 U.S. Patients With ALS Treated With RADICAVA® (edaravone) In Two Years Since Availability, Mitsubishi Tanabe Pharma America Reports
Jun 03, 2019
Statement from Deputy Commissioners Amy Abernethy, M.D., Ph.D., and Frank Yiannas on warning for women of childbearing age about possible safety risks of dietary supplements containing vinpocetine
May 29, 2019
Lannett Commences Marketing Generic Concerta®
May 16, 2019
Lannett Begins Marketing Generic Adderall®
May 06, 2019
MTPA Announces Nationwide Database Of ALS Infusion Services To Help Patients And Caregivers Identify Local Providers
May 03, 2019
Oxford BioDynamics Joins ALS Biomarker Study Sponsored By Mitsubishi Tanabe Pharma America
May 02, 2019
Post-Hoc Analyses of RADICAVA® (edaravone) Studies Show Phase 3 Study Design Minimized ALS Heterogeneity to Improve Trial Efficiency